GENEMATRIX, Inc. engages in the development of platform and molecular diagnostics products. Its products include pharmaceutical products for respiratory, sexually transmitted, human papillomavirus, and gastrointestinal infections. The company was founded on December 7, 2000 and is headquartered in Seongnam-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company